MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Delcath to pare 20% of its U.S. workforce | Personnel Moves

Delcath to pare 20% of its U.S. workforce | Personnel Moves

By

fired/hired

Queensbury, N.Y.-based Delcath (NSDQ:DCTH) announced last week that it plans to pare its workforce by about 20%, the latest in a series of layoff announcements from the oncology devices maker. This is the 3rd time this year that Delcath has announced imminent layoffs, having announced smaller cuts in April and larger layoffs in January.

The terminations come in the wake of the device maker’s breakdown at the FDA. The FDA’s Oncologic Drugs Advisory Committee in May voted 16-0 that the risks associated with Delcath’s Melblez Kit are higher than its potential benefits for patients with unresectable ocular melanoma metastatic to the liver.

Delcath reported that the cuts are an attempt to "better focus the company’s organizational structure and concentrate financial resources on its clinical development program and European commercialization," noting that European operations will not be impacted by the layoffs.

New of the layoffs was contained in a press release announcing the appointment of William Appling to take over as both the head of R&D and head of global operations. Appling, who has worked for the company for 3 years, will take over for former executive VP of global operations, Harold Mapes, and for former R&D executive Krishna Kandarpa.

"The actions we announced today are designed to further increase our organizational efficiencies with a goal of reducing our expected cash burn in the fourth quarter to approximately 50% of what it was in the 2nd quarter of 2012," Delcath CEO Eamonn Hobbs said in prepared remarks. "Our team continues to be focused on our key strategic priorities in clinical development and European commercialization."

 Hansen Medical legal exec flies the coop
Carolyn Bruguera left Hansen Medical’s (NSDQ:HNSN) legal team June 28. The former VP & general counsel joined the robot surgery systems company in January 2012 following 6 years at Micrus Endovascular Corp.
Read more

 A quick goodbye for NeuroMetrix’s COO
NeuroMetrix (NSDQ:NURO) operations chief Krishnamurthy Balachandran announced his resignation on June 27 and walked out the door 3 days later, according to regulatory filings. Balachandran was the senior VP, general manager of international & COO.
Read more

 New top dog at RF Surgical Systems
RF Surgical Systems pulled John Buhler in as CEO of the company following his role as COO of Natus Medical (NSDQ:BABY). Buhler has also held executive roles at SenoRx and GE (NYSE:GE). Buhler replaced former CEO Kevin Cosens, who was at the helm for 7 years.
Read more

 bioTheranostics adds 2 doctors to its executive team
Cancer diagnostics company bioTheranostics hired Dr. Michael Dugan as CMO and Catherine Schnabel as VP of medical, clinical & regulatory affairs. Dugan was the former CMO of Roche Molecular Systems and previously worked at UCLA. Schnabel’s career spanned executive and research roles at Amylin Pharmaceuticals, Genoptix and Genentech.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]

Leave a Reply